What is Superluminal Medicines worth?
$189.9Mlast known valuation
Superluminal Medicines last raised $5.0M in its Debt (Aug 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Superluminal Medicines
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2025 | Debt | $5.0M | ▮ | ▮ |
| Jan 2025 | Early Stage VC (Series A) | $120.0M | ▮ | ▮ |
| Aug 2023 | Seed Round | $32.7M | ▮ | ▮ |
How Superluminal Medicines's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Superluminal Medicines, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Superluminal Medicines worth?
- Superluminal Medicines's last known valuation is $189.9M.
- How much has Superluminal Medicines raised?
- Superluminal Medicines has raised $157.7M in total funding across 3 recorded rounds.
- When did Superluminal Medicines last raise?
- Superluminal Medicines last raised in Aug 2025 (Debt), raising $5.0M.